News Releases Year: - Any -2021202020192018201720162015201420132012 Items per page 102550 10/13/21 Summary ToggleClearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Specialists (ASRS) Annual Meeting PDF Version 10/04/21 Summary ToggleClearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scientific Meeting PDF Version 09/21/21 Summary ToggleClearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients PDF Version 09/09/21 Summary ToggleClearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries PDF Version 08/23/21 Summary ToggleClearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum PDF Version 08/10/21 Summary ToggleClearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update PDF Version 08/04/21 Summary ToggleClearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 PDF Version 07/27/21 Summary ToggleClearside Biomedical to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Tuesday, August 10, 2021 PDF Version 06/15/21 Summary ToggleClearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD PDF Version 06/09/21 Summary ToggleClearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021 PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page Last
